|
End-of-day quote
NORDIC GROWTH MARKET
2026-08-20
|
5-day change | 1st Jan Change | ||
| 9.100 DKK | +4.84% |
|
-8.82% | -42.98% |
| 07-24 | CHMP says no to KemSu, review requested | FW |
| 06-12 | Cessatech partners with Rigshospitalet for CT004 development | FW |
Company Valuation: Cessatech A/S
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Market Cap 1 | 72.86 | 102.8 | 22.27 | 100.1 | 205.6 |
| Change | - | 41.1% | -78.34% | 349.54% | 105.4% |
| Enterprise Value (EV) 1 | 59.36 | 99.54 | -1.074 | 96.73 | 193.2 |
| Change | - | 67.69% | -101.08% | 9,105.48% | 99.77% |
| P/E | -27x | -5.44x | -0.78x | -3.77x | -13.9x |
| PBR | 5.35x | 3.92x | 0.93x | -52.2x | 24.9x |
| PEG | - | -0x | 0x | 0.55x | 0.2x |
| Capitalization / Revenue | - | - | - | - | 82,709,617x |
| EV / Revenue | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - |
| EV / EBIT | -49.4x | -7.2x | 0.06x | -4.3x | -10.1x |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -0.7333 | -3.09 | -2.064 | -1.924 | -0.8505 |
| Distribution rate | - | - | - | - | - |
| Net sales | - | - | - | - | 2.486 |
| EBITDA | - | - | - | - | - |
| EBIT 1 | -1.201 | -13.83 | -17.59 | -22.51 | -19.05 |
| Net income 1 | -1.132 | -11.57 | -14.66 | -26.53 | -14.67 |
| Net Debt 1 | -13.51 | -3.275 | -23.34 | -3.373 | -12.37 |
| Reference price 2 | 19.800 | 16.820 | 1.615 | 7.260 | 11.800 |
| Nbr of stocks (in thousands) | 3,680 | 6,113 | 13,789 | 13,789 | 17,425 |
| Announcement Date | 3/11/21 | 3/1/22 | 2/28/23 | 2/29/24 | 2/28/25 |
1DKK in Million2DKK
Estimates
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CESSA Stock
- Valuation Cessatech A/S
Select your edition
All financial news and data tailored to specific country editions
